AOP

“GLP-1 and Dual GIP/GLP-1 Receptor Agonists: From Science to Practice – Incretin-Based Therapies in Modern Metabolic Medicine” Master Class has been officially accredited by the European Accreditation Council for Continuing Medical Education (EACCME®).

Participants will receive 13.0 European CME credits (ECMEC®s) upon completion.

📅 April 10–11, 2026
📍 Best Western Plus Congress Hotel Yerevan
This international Master Class will bring together physicians and experts from across Europe to explore the latest scientific and clinical advances in incretin-based therapies for type 2 diabetes and obesity.
👉 Register now: www.aop.am/conference

Diabetes Obesity Yerevan HealthcareProfessionals

🔬 Why GLP-1 Therapies Are Transforming Medicine
▪️ Up to 20-22% weight loss
▪️ Cardiovascular protection
▪️ Renal benefits
▪️ Superior glycemic control
Learn how to integrate these breakthrough therapies into your practice.
📅 April 10-11, 2026 | Yerevan
🌐 www.aop.am/conference